查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1978943

支气管内超音波切片检查设备市场：按产品类型、产品系列、适应症、应用和最终用户划分－2026-2032年全球市场预测

Endobronchial Ultrasound Biopsy Devices Market by Product Type, Product Offering, Indication, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，超音波切片检查设备市场价值将达到 7.3874 亿美元，到 2026 年将增长至 7.8505 亿美元，到 2032 年将达到 12.0727 亿美元，复合年增长率为 7.26%。

主要市场统计数据
基准年 2025 7.3874亿美元
预计年份：2026年 7.8505亿美元
预测年份 2032 12.0727亿美元
复合年增长率 (%) 7.26%

对超音波切片检查技术的临床价值、技术基础和影响其应用的策略因素进行了全面概述。

支气管内超音波切片检查设备将影像和组织取样整合于单一操作流程中，已成为现代呼吸医学中重要的诊断工具。这些设备结合了支气管镜检查和超音波影像，提高了纵膈和周围肺部病变定位和取样的准确性。临床医生正在利用这项技术提高诊断准确性，减少重复治疗，并支持肿瘤科、感染疾病和间质性肺病科等多个学科的决策。

新的技术进步和临床工作流程的变革正在重新定义超音波切片检查护理的准确性、安全性和操作整合性。

近年来，支气管内超音波切片检查设备领域发生了变革性的变化，这体现在影像解析度的提升、一次性耗材策略的改进以及复杂手术向门诊的转移。探头设计和讯号处理的改进使得病灶和淋巴结的显像更加清晰，从而能够更精准地进行经支气管针吸活检，并降低无法诊断检体的比例。同时，製造商正优先研发一次性针头套装和保护鞘套，以简化无菌操作流程并降低交叉感染的风险，这在后疫情时代的临床管治中尤其重要。

美国关税调整重组了供应链和筹资策略，增强了供应链的韧性，促进了整个医疗设备生态系统的供应商多元化和区域製造能力。

2025年美国关税调整的累积影响已波及全球医疗设备供应链，迫使製造商和医疗服务提供者重新评估其超音波切片检查设备的筹资策略。关税导致进口零件成本上升，推高了製造成本，尤其是那些依赖跨境生产关键子组件和专用超音波换能器的公司。为因应这项挑战，各公司加快了供应商多元化步伐，尽可能转向本地供应商，并在某些情况下优先投资本地生产，以降低未来政策变化带来的风险。

详细的细分观点揭示了产品类型、产品供应、最终用户、应用和临床适应症如何独特地影响设备的选择和实施。

从产品类型、产品线、终端用户、应用和临床适应症等角度对市场检验細項分析，可以清楚揭示市场绩效驱动因素和进入路径。就产品类型而言，此领域可分为纵向探针和径向探针。纵向探针可在引导下直接观察纵膈和肺门淋巴结的穿刺活检，而径向探针则擅长对周围病变进行立体定位，从而实现互补的诊断策略。就产品而言，成像工作站和内视镜系统等设备投资构成了资本规划和综合成本的基础，而针组和保护鞘套等耗材则影响持续支出和手术能力。

美洲、欧洲、中东和非洲以及亚太地区的部署模式和商业性需求塑造了部署、培训和售后市场策略。

区域趋势正显着影响着美洲、欧洲、中东和非洲以及亚太地区的采用模式、监管预期和商业策略。在美洲，先进的三级医疗中心和强大的介入呼吸计画集中分布，推动了整合影像工作站和先进内视镜系统的早期应用；与此同时，保险公司也日益关注手术流程，以确保成本效益和治疗效果的一致性。手术向门诊手术中心转移，催生了新的采购重点，这些重点围绕着设备的移动性、易用性和耗材生命週期管理。

竞争格局分析重点在于各种策略模式，从整合平台供应商到耗材专家，以及它们对采购和临床部署的影响。

支气管内超音波切片检查领域的主要企业正在展现出广泛的策略倡议，从平台整合产品到以耗材为中心的经营模式，不一而足。成熟的内视镜製造商专注于系统层面的差异化，将高解析度成像工作站与模组化内视镜架构相结合，以主导手术生态系统并促进耗材的辅助销售。这些公司强调长期服务合约、临床医生培训计划以及捆绑式解决方案，以促进医院整合并简化采购谈判。

为製造商和医疗保健提供者提供切实可行的、有影响力的策略行动，以增强临床应用、供应链韧性和设备的长期价值。

产业领导者若想巩固市场地位并支持永续的临床应用，应采取一系列切实可行的策略，使创新与实际操作相契合。首先，应优先考虑内视镜系统与成像工作站之间的端到端集成，以实现无缝的临床工作流程，并减轻临床医生的工作负担。引入全面的培训课程和基于模拟的认证项目，可以加快技能提升，最大限度地减少切片检查技术的差异，从而提高检体品质和临床医生的信心。

采用稳健的混合方法研究途径，结合专家访谈、临床文献综述和基于三角测量的数据分析，以验证检验并减少偏见。

本分析的调查方法结合了严谨的一手和二手调查方法，以确保分析的深度和有效性。一手资料收集包括对介入手术医生、生物医学工程师、检体采集部门负责人和医院管理人员进行结构化访谈，以了解他们在设备性能、培训需求和耗材物流的真实经验。这些专家意见体现在对临床工作流程、设备人体工学和手术瓶颈的评估中。

整合策略重点，强调技术进步、供应链调整和协调的临床策略，以最大限度地提高诊断效果。

总之，支气管内超音波切片检查设备在诊断准确性、手术安全性和操作效率方面占据战略地位。探头设计、影像工作站和一次性耗材的技术创新正在提高诊断效能，同时也正在重塑门诊手术中心、医院和专科诊所的手术操作方式。同时，关税和报销政策变化等外部压力正迫使製造商和医疗机构重新思考其采购、定价和商业化模式。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：超音波切片检查设备市场：依产品类型划分

  • 线性探头
  • 径向探针

第九章：超音波切片检查设备市场（依产品类别划分）

  • 消耗品
    • 针具套装
    • 保护鞘套
  • 装置
    • 医学影像工作站
    • 内视镜系统

第十章：超音波切片检查设备市场：依适应症划分

  • 癌症诊断
  • 感染疾病
  • 类肉瘤病

第十一章：超音波切片检查设备市场：依应用领域划分

  • 纵膈分期
  • 週边性病变的诊断
  • 经支气管针吸切片

第十二章：超音波切片检查设备市场：依最终用户划分

  • 门诊手术中心
  • 医院
  • 专科诊所

第十三章：超音波切片检查设备市场：按地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章：超音波切片检查设备市场：依类别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章：超音波切片检查设备市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国支气管内超音波切片检查设备市场

第十七章：中国支气管内超音波切片检查设备市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • ACE Medical Devices Pvt. Ltd.
  • Argon Medical Devices
  • Boston Scientific Corporation
  • Cook Group Incorporated
  • EndoMed Systems GmbH
  • FUJIFILM Corporation
  • Huger Medical Instrument Co., Ltd.
  • Hunan Vathin Medical Instrument Co., Ltd.
  • Medi-Globe Technologies GmbH by DCC PLC
  • Medtronic PLC
  • Micro-Tech Endoscopy
  • Olympus Corporation
  • Siemens AG
  • STERYLAB Srl
  • TSK Laboratory International
  • Zamar Care
  • Zhuhai Pusen Medical Technology Co., Ltd.
Product Code: MRR-521BAA36EA81

The Endobronchial Ultrasound Biopsy Devices Market was valued at USD 738.74 million in 2025 and is projected to grow to USD 785.05 million in 2026, with a CAGR of 7.26%, reaching USD 1,207.27 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 738.74 million
Estimated Year [2026] USD 785.05 million
Forecast Year [2032] USD 1,207.27 million
CAGR (%) 7.26%

Comprehensive overview of clinical value, technological underpinnings, and strategic factors shaping adoption of endobronchial ultrasound biopsy technologies

Endobronchial ultrasound biopsy devices have emerged as a pivotal diagnostic modality within modern pulmonary care, bridging imaging and tissue acquisition in a single procedural workflow. These devices combine bronchoscopic access with real-time ultrasound visualization to improve localization and sampling of mediastinal and peripheral pulmonary lesions. Clinicians deploy the technology to enhance diagnostic yield, reduce repeat procedures, and support multidisciplinary decision-making across oncology, infectious disease, and interstitial lung disease programs.

Technologically, the field has matured from foundational ultrasound probes to integrated systems that emphasize ergonomics, imaging fidelity, and single-use consumables that lower cross-contamination risk. As procedural pathways evolve, payers and hospital systems increasingly evaluate not just device performance but also throughput, inventory complexity, and lifecycle costs. Consequently, procurement and clinical teams must consider device interoperability, training requirements, and post-market surveillance data when adopting or upgrading endobronchial ultrasound platforms.

This introduction frames the clinical value proposition, the convergence of imaging and biopsy capabilities, and the strategic considerations that healthcare organizations should weigh when assessing investment in endobronchial ultrasound biopsy technology. It sets the stage for subsequent analysis of technological shifts, regulatory influences, and supply chain factors that collectively shape adoption and clinical integration.

Emerging technological advancements and clinical workflow metamorphoses that are redefining precision, safety, and operational integration of endobronchial ultrasound biopsy care

Recent transformative shifts in the landscape of endobronchial ultrasound biopsy devices reflect advances in imaging resolution, single-use consumable strategies, and the migration of complex procedures into ambulatory settings. Improved probe design and signal processing have sharpened visualization of lesions and lymph nodes, enabling more precise transbronchial needle aspiration and reducing nondiagnostic samples. Simultaneously, manufacturers have prioritized disposable needle sets and protective sheaths that streamline sterilization workflows and mitigate cross-infection risks, which is particularly salient in post-pandemic clinical governance.

Concurrently, the evolution of integrated imaging workstations and scope systems has enhanced data capture, enabling smoother integration with electronic health records and procedural documentation. These developments support multidisciplinary tumor boards by delivering higher-fidelity images and biopsy metadata for longitudinal care decisions. In addition, the diffusion of the technology into ambulatory surgical centers and specialty clinics reflects procedural reimbursement shifts and efforts to improve patient throughput while containing costs.

Looking forward, artificial intelligence-assisted image interpretation and procedural guidance are likely to further alter clinician workflows, improving lesion targeting and standardizing sampling strategies. As a result, stakeholders must adapt training curricula, refine credentialing frameworks, and reassess capital planning to align with a landscape that increasingly values precision, safety, and operational efficiency.

Supply chain resilience and procurement strategies reshaped by United States tariff adjustments, driving supplier diversification and regional manufacturing responses across device ecosystems

The cumulative impact of United States tariff adjustments in 2025 has reverberated across global medical device supply chains, compelling manufacturers and healthcare providers to reassess sourcing and procurement strategies for endobronchial ultrasound biopsy devices. Tariff-driven increases in component import costs have created upward pressure on manufacturing expenses, particularly for firms that rely on cross-border production of critical subassemblies and specialized ultrasound transducers. Firms responded by accelerating supplier diversification, shifting to regional vendors where feasible, and, in some cases, reprioritizing local manufacturing investments to mitigate future policy volatility.

On the clinical procurement side, acute awareness of tariff risk has prompted hospital systems and group purchasing organizations to negotiate longer-term supply contracts and to emphasize total cost of ownership in purchasing decisions. These negotiations increasingly consider consumable availability and aftermarket support as essential elements of device value. In parallel, manufacturers have sought to absorb some cost burdens through process improvements, lean manufacturing, and design choices that reduce reliance on tariff-impacted inputs.

Finally, regulatory and contracting teams have become more vigilant in modeling supplier continuity and in requiring transparent disclosure of sourcing footprints. For stakeholders, the tariff landscape underscores the importance of scenario planning, diversified supplier networks, and contract clauses that address cost pass-through to maintain predictable access to endobronchial ultrasound biopsy devices and related consumables.

In-depth segmentation perspective illuminating how product types, offerings, end users, applications, and clinical indications uniquely influence device selection and adoption

Segmentation analysis reveals distinct performance drivers and adoption pathways when the market is examined through product type, product offering, end user, application, and clinical indication lenses. By product type, the field differentiates devices that utilize linear probes, which afford direct visualization for guided needle aspiration of mediastinal and hilar nodes, and radial probes, which excel at peripheral lesion localization and enable complementary diagnostic strategies. When viewed by product offering, equipment investments-such as imaging workstations and scope systems-anchor capital planning and integration costs, while consumables, including needle sets and protective sheaths, shape recurrent spending and procedural throughput.

End-user contexts further nuance adoption dynamics: ambulatory surgical centers prioritize compact, efficient systems and streamlined consumables to support high-throughput outpatient procedures; hospitals emphasize advanced imaging capabilities, broad device interoperability, and comprehensive service agreements; and specialty clinics seek cost-effective configurations that balance diagnostic performance with space and staffing constraints. Applications span mediastinal staging, which demands high precision and reproducibility for staging decisions; peripheral lesion diagnosis, where lesion accessibility and imaging resolution are decisive; and transbronchial needle aspiration, which combines imaging and tissue acquisition and stresses needle design and sampling ergonomics.

Finally, clinical indications-ranging from cancer diagnostics to infectious disease evaluation and sarcoidosis assessment-influence both device selection and procedural protocols, as tissue adequacy, sample handling, and downstream molecular testing requirements vary substantially across these diagnostic pathways.

Regional adoption patterns and commercial imperatives across the Americas, Europe, Middle East & Africa, and Asia-Pacific that shape deployment, training, and aftermarket strategies

Regional dynamics exert a pronounced influence on adoption patterns, regulatory expectations, and commercial strategies across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, a concentration of advanced tertiary care centers and robust interventional pulmonology programs supports early adoption of integrated imaging workstations and advanced scope systems, while payers increasingly scrutinize procedural pathways for cost-effectiveness and outcome alignment. Transitioning procedures to ambulatory surgical settings is creating new procurement priorities centered on mobility, ease of use, and consumable lifecycle management.

Within Europe, Middle East & Africa, heterogeneous regulatory environments and variable hospital funding models drive a mixture of centralized hospital deployments and targeted specialty clinic adoption. Manufacturers often tailor their market entry strategies to national reimbursement frameworks and to regional training partnerships with clinical societies. The Asia-Pacific region demonstrates accelerated uptake in urban tertiary centers and an expanding installed base driven by investments in cancer diagnostics infrastructure, with localized manufacturing and regional distribution partnerships playing pivotal roles in cost control and service responsiveness.

Across these regions, common themes emerge: emphasis on clinician training, the importance of service and warranty ecosystems, and the strategic role of consumables management in sustaining procedural volume. Decision-makers should therefore evaluate regional regulatory pathways, reimbursement nuances, and local clinical practice patterns when planning market entry or expansion.

Competitive landscape analysis highlighting divergent strategic models from integrated platform providers to consumable specialists and the implications for procurement and clinical adoption

Key companies within the endobronchial ultrasound biopsy ecosystem demonstrate a range of strategic approaches, from platform-integrated offerings to consumable-focused business models. Established endoscope manufacturers have leaned into system-level differentiation, combining high-resolution imaging workstations with modular scope architectures to capture procedural ecosystems and to drive consumable attachment. These firms emphasize long-term service contracts, clinician training programs, and bundled solutions that facilitate hospital integration and simplify procurement conversations.

Simultaneously, specialized manufacturers of needle systems and protective sheaths prioritize engineering focused on sampling reliability, tissue integrity, and single-use convenience. Their commercial strategies center on clinical evidence that demonstrates improved diagnostic yield and reduced repeat procedure rates, supported by targeted educational initiatives for interventional pulmonologists and cytopathology teams. Newer entrants and niche innovators often focus on adjunct technologies-such as navigation aids, biopsy forceps, or AI-enabled image enhancement-seeking strategic partnerships with platform holders to accelerate clinical adoption.

Overall, competitive dynamics are shaped by a balance between integrated platforms that lock in recurring consumable revenue and specialist suppliers that win on clinical performance and cost-efficient single-use designs. For purchasers, this dynamic increases the importance of evaluating total contractual arrangements, service level agreements, and the long-term roadmap for interoperability and software support.

Practical and high-impact strategic actions for manufacturers and healthcare providers to enhance clinical adoption, supply chain resilience, and long-term device value

Industry leaders seeking to strengthen market position and support sustainable clinical adoption should pursue a set of actionable strategies that align innovation with operational realities. First, prioritize end-to-end integration between scope systems and imaging workstations to deliver seamless clinical workflows and to reduce clinician friction at the point of care. Embedding robust training curricula and simulation-based credentialing will accelerate proficiency and minimize variability in biopsy technique, thereby improving sample quality and clinician confidence.

Second, develop resilient supply chains by diversifying component sourcing and by investing in regional manufacturing or assembly capabilities where feasible to mitigate trade and tariff exposure. Third, align commercial models with clinical workflows by offering flexible procurement options that address capital constraints, such as subscription-based access to imaging workstations combined with predictable consumable pricing. Fourth, invest in post-market evidence generation that demonstrates the impact of devices on diagnostic yield, downstream treatment decision-making, and patient experience, thereby supporting reimbursement discussions and hospital formulary inclusion.

Finally, foster interoperability and open data architectures to enable integration with electronic health records and multidisciplinary care platforms. These steps collectively will help firms and health systems navigate evolving clinical expectations, regulatory scrutiny, and fiscal pressures while expanding access to advanced endobronchial ultrasound biopsy capabilities.

Robust mixed-methods research approach integrating expert interviews, clinical literature review, and triangulated data analysis to validate insights and limit bias

The research methodology underpinning this analysis combined rigorous primary and secondary research techniques to ensure analytic depth and validity. Primary data collection included structured interviews with interventional pulmonologists, biomedical engineers, procurement leaders, and hospital administrators to capture real-world experiences with device performance, training needs, and consumable logistics. These expert inputs informed assessments of clinical workflows, device ergonomics, and procedural bottlenecks.

Secondary research encompassed a review of peer-reviewed clinical publications, device labeling and regulatory filings, clinical society guidelines, and publicly available regulatory communications to corroborate safety and efficacy claims and to map technology trends. Data triangulation ensured that insights reflected convergent evidence across sources, and sensitivity analyses were applied where qualitative inputs varied among experts. Segment definitions and regional analyses were constructed to align with clinical practice patterns, reimbursement frameworks, and supply chain geographies.

Limitations of the methodology include evolving regulatory landscapes and the pace of technological innovation, both of which can alter device capabilities and adoption dynamics. To address this, the research team applied conservative interpretation of nascent technologies and prioritized peer-reviewed evidence where available. Ethical considerations included anonymizing interview participants and securing consent for the use of proprietary insights in aggregate analysis.

Synthesis of strategic takeaways emphasizing technological progress, supply chain adaptation, and coordinated clinical strategies to maximize diagnostic outcomes

In conclusion, endobronchial ultrasound biopsy devices occupy a strategic position at the intersection of diagnostic precision, procedural safety, and operational efficiency. Technological innovations in probe design, imaging workstations, and single-use consumables are improving diagnostic performance while reshaping how procedures are delivered across ambulatory surgical centers, hospitals, and specialty clinics. At the same time, external pressures such as tariff-induced supply chain adjustments and evolving reimbursement practices are prompting manufacturers and providers to rethink sourcing, pricing, and commercialization models.

Successful deployment requires a holistic view that considers device interoperability, clinician training, consumable lifecycle management, and post-market evidence generation. By aligning product development with real-world clinical workflows and by establishing resilient supply chains, stakeholders can accelerate adoption while managing total cost of ownership and regulatory expectations. Ultimately, the balance between integrated platforms and high-performance consumables will determine how institutions structure purchasing decisions and how clinicians deliver consistent, high-quality diagnostic outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Endobronchial Ultrasound Biopsy Devices Market, by Product Type

  • 8.1. Linear Probe
  • 8.2. Radial Probe

9. Endobronchial Ultrasound Biopsy Devices Market, by Product Offering

  • 9.1. Consumables
    • 9.1.1. Needle Sets
    • 9.1.2. Protective Sheaths
  • 9.2. Equipment
    • 9.2.1. Imaging Workstations
    • 9.2.2. Scope Systems

10. Endobronchial Ultrasound Biopsy Devices Market, by Indication

  • 10.1. Cancer Diagnostics
  • 10.2. Infectious Diseases
  • 10.3. Sarcoidosis

11. Endobronchial Ultrasound Biopsy Devices Market, by Application

  • 11.1. Mediastinal Staging
  • 11.2. Peripheral Lesion Diagnosis
  • 11.3. Transbronchial Needle Aspiration

12. Endobronchial Ultrasound Biopsy Devices Market, by End User

  • 12.1. Ambulatory Surgical Centers
  • 12.2. Hospitals
  • 12.3. Specialty Clinics

13. Endobronchial Ultrasound Biopsy Devices Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Endobronchial Ultrasound Biopsy Devices Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Endobronchial Ultrasound Biopsy Devices Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Endobronchial Ultrasound Biopsy Devices Market

17. China Endobronchial Ultrasound Biopsy Devices Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. ACE Medical Devices Pvt. Ltd.
  • 18.6. Argon Medical Devices
  • 18.7. Boston Scientific Corporation
  • 18.8. Cook Group Incorporated
  • 18.9. EndoMed Systems GmbH
  • 18.10. FUJIFILM Corporation
  • 18.11. Huger Medical Instrument Co., Ltd.
  • 18.12. Hunan Vathin Medical Instrument Co., Ltd.
  • 18.13. Medi-Globe Technologies GmbH by DCC PLC
  • 18.14. Medtronic PLC
  • 18.15. Micro-Tech Endoscopy
  • 18.16. Olympus Corporation
  • 18.17. Siemens AG
  • 18.18. STERYLAB S.r.l
  • 18.19. TSK Laboratory International
  • 18.20. Zamar Care
  • 18.21. Zhuhai Pusen Medical Technology Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT OFFERING, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY LINEAR PROBE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY LINEAR PROBE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY LINEAR PROBE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY RADIAL PROBE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY RADIAL PROBE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY RADIAL PROBE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT OFFERING, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CONSUMABLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY NEEDLE SETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY NEEDLE SETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY NEEDLE SETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PROTECTIVE SHEATHS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PROTECTIVE SHEATHS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PROTECTIVE SHEATHS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY EQUIPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY EQUIPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY IMAGING WORKSTATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY IMAGING WORKSTATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY IMAGING WORKSTATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY SCOPE SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY SCOPE SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY SCOPE SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CANCER DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CANCER DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CANCER DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY SARCOIDOSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY SARCOIDOSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY SARCOIDOSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY MEDIASTINAL STAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY MEDIASTINAL STAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY MEDIASTINAL STAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PERIPHERAL LESION DIAGNOSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PERIPHERAL LESION DIAGNOSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PERIPHERAL LESION DIAGNOSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY TRANSBRONCHIAL NEEDLE ASPIRATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY TRANSBRONCHIAL NEEDLE ASPIRATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY TRANSBRONCHIAL NEEDLE ASPIRATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. AMERICAS ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 62. AMERICAS ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 63. AMERICAS ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT OFFERING, 2018-2032 (USD MILLION)
  • TABLE 64. AMERICAS ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 65. AMERICAS ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 66. AMERICAS ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 67. AMERICAS ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 68. AMERICAS ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 69. NORTH AMERICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. NORTH AMERICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 71. NORTH AMERICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT OFFERING, 2018-2032 (USD MILLION)
  • TABLE 72. NORTH AMERICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 73. NORTH AMERICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 74. NORTH AMERICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 75. NORTH AMERICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 76. NORTH AMERICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 77. LATIN AMERICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. LATIN AMERICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 79. LATIN AMERICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT OFFERING, 2018-2032 (USD MILLION)
  • TABLE 80. LATIN AMERICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 81. LATIN AMERICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 82. LATIN AMERICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 84. LATIN AMERICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT OFFERING, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE, MIDDLE EAST & AFRICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE, MIDDLE EAST & AFRICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE, MIDDLE EAST & AFRICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT OFFERING, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 101. MIDDLE EAST ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. MIDDLE EAST ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. MIDDLE EAST ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT OFFERING, 2018-2032 (USD MILLION)
  • TABLE 104. MIDDLE EAST ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 105. MIDDLE EAST ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 106. MIDDLE EAST ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 107. MIDDLE EAST ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 108. MIDDLE EAST ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 109. AFRICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. AFRICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 111. AFRICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT OFFERING, 2018-2032 (USD MILLION)
  • TABLE 112. AFRICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 113. AFRICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 114. AFRICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 115. AFRICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 116. AFRICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT OFFERING, 2018-2032 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 126. ASEAN ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. ASEAN ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. ASEAN ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT OFFERING, 2018-2032 (USD MILLION)
  • TABLE 129. ASEAN ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 130. ASEAN ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 131. ASEAN ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 132. ASEAN ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 133. ASEAN ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. GCC ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. GCC ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. GCC ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT OFFERING, 2018-2032 (USD MILLION)
  • TABLE 137. GCC ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 138. GCC ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 139. GCC ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 140. GCC ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 141. GCC ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPEAN UNION ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPEAN UNION ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPEAN UNION ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT OFFERING, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPEAN UNION ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPEAN UNION ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPEAN UNION ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPEAN UNION ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPEAN UNION ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 150. BRICS ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 151. BRICS ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. BRICS ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT OFFERING, 2018-2032 (USD MILLION)
  • TABLE 153. BRICS ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 154. BRICS ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 155. BRICS ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 156. BRICS ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 157. BRICS ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 158. G7 ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. G7 ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. G7 ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT OFFERING, 2018-2032 (USD MILLION)
  • TABLE 161. G7 ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 162. G7 ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 163. G7 ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 164. G7 ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 165. G7 ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 166. NATO ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 167. NATO ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. NATO ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT OFFERING, 2018-2032 (USD MILLION)
  • TABLE 169. NATO ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 170. NATO ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 171. NATO ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 172. NATO ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 173. NATO ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 174. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. UNITED STATES ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 176. UNITED STATES ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. UNITED STATES ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT OFFERING, 2018-2032 (USD MILLION)
  • TABLE 178. UNITED STATES ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 179. UNITED STATES ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 180. UNITED STATES ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 181. UNITED STATES ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 182. UNITED STATES ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 183. CHINA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 184. CHINA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. CHINA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT OFFERING, 2018-2032 (USD MILLION)
  • TABLE 186. CHINA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 187. CHINA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 188. CHINA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 189. CHINA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 190. CHINA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)